• High TXNIP expression correlates with improved overall survival in pancreatic cancer patients.
• Overexpression of TXNIP suppresses proliferation and migration of pancreatic cancer cells in vitro.
• TXNIP inhibits the MAPK signaling pathway, particularly via dephosphorylation of Erk1/2.
• TXNIP emerges as a novel prognostic marker and potential therapeutic target for pancreatic cancer.
Download Full PDF: Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway | SinoBioData | SinoBioData